Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that Caroline J. Loew, Ph.D., has been appointed as the chief executive officer designate of Mural...

Related Keywords

Athlone ,Westmeath ,Ireland ,Dublin ,Cambridge ,Cambridgeshire ,United Kingdom ,Ohio ,United States ,Waltham ,Massachusetts ,London ,City Of ,Carolinej Loew ,Glympse Bio ,Jit Bhowmick ,Katie Joyce ,Caroline Loew ,Sandy Coombs ,Nasdaq ,Alkermes ,Drug Administration ,Imperial College London ,Exchange Commission ,Assume New Leadership Role Upon Completion ,Planned Separation ,Alkerme Oncology Business ,Planned Separation Remains ,Second Half ,Mural Oncology ,Richard Pops ,Vice President ,Bristol Myers Squibb ,Norganic Chemistry ,Imperial College ,United States Securities ,Nemvaleukin Alfa ,Private Securities Litigation Reform Act ,Annual Report ,Alkermes Plc ,